Compare · CGC vs RGC
CGC vs RGC
Side-by-side comparison of Canopy Growth Corporation (CGC) and Regencell Bioscience Holdings Limited (RGC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CGC and RGC operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- RGC is the larger of the two at $2.07B, about 11.3x CGC ($183.7M).
- Over the past year, CGC is down 62.3% and RGC is down 62.7% - CGC leads by 0.4 points.
- Both names hit the wire about 3 times in the past 4 weeks.
- CGC has more recent analyst coverage (19 ratings vs 0 for RGC).
- Company
- Canopy Growth Corporation
- Regencell Bioscience Holdings Limited
- Price
- -
- -
- Market cap
- $183.7M
- $2.07B
- 1M return
- -35.03%
- -57.33%
- 1Y return
- -62.27%
- -62.69%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- News (4w)
- 3
- 3
- Recent ratings
- 19
- 0
Canopy Growth Corporation
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Bean & Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and NHL Alumni Association to examine the efficacy of CBD-based therapies as part of the mitigation of persistent post-concussion symptoms. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Latest CGC
- Canopy Growth Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Canopy Growth Reports Second Quarter Fiscal Year 2027 Financial Results; Net Revenue Growth of 22% Led by a 141% Increase in International Markets Cannabis
- SEC Form 10-Q filed by Canopy Growth Corporation
- Canopy Growth Announces Results of 2026 Annual General and Special Meeting of Shareholders
- SEC Form 8-K filed by Canopy Growth Corporation
- Canopy Growth to Report Second Quarter Fiscal 2027 Financial Results on November 6, 2026
- SEC Form DEFA14A filed by Canopy Growth Corporation
- SEC Form 8-K filed by Canopy Growth Corporation
- Canopy Growth’s Smiths Falls Facility Becomes Canada’s Only EU GMP-Certified Site Combining Softgel Manufacturing With Primary Packaging of Softgels, Oral Liquids and Dried Cannabis Flower
- SEC Form DEFA14A filed by Canopy Growth Corporation
Latest RGC
- Director Lo William Wing Yan Dr exercised 36,001 units of Ordinary shares at a strike of $0.84, increasing direct ownership by 8% to 485,629 units (SEC Form 4)
- SEC Form 144 filed by Regencell Bioscience Holdings Limited
- SEC Form S-8 filed by Regencell Bioscience Holdings Limited
- SEC Form 20-F filed by Regencell Bioscience Holdings Limited
- SEC Form 4 filed by Director Lo William Wing Yan Dr
- SEC Form 4 filed by Director Hui Evana Yee Wah
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 424B5 filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited